Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: Report of a case

Pediatric Nephrology

Volumn 27, Issue 10, 2012, Pages 1995-1999

  Gnappi, Elisa ^a   Allinovi, Marco ^a   Vaglio, Augusto ^a   Bresin, Elena ^b   Sorosina, Annalisa ^b   Pilato, Francesco P ^a   Allegri, Landino ^a   Manenti, Lucio ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Atypical hemolytic uremic syndrome (aHUS); Complement dysregulation; Complement factor H (CFH) mutations; Glomerulopathies; Membranoproliferative glomerulonephritis (MPGN)

Indexed keywords

COMPLEMENT FACTOR H; CREATININE; CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; HAPTOGLOBIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; NEPHRITIC FACTOR; PREDNISONE; RAMIPRIL;

ADOLESCENT; ANAMNESIS; ARTICLE; BLOOD SMEAR; CASE REPORT; CREATININE BLOOD LEVEL; FIBROSING ALVEOLITIS; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; GLOMERULOSCLEROSIS; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; BIOPSY; COMPLEMENT FACTOR H; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MALE; MUTATION; PHENOTYPE; PLASMA EXCHANGE; TREATMENT OUTCOME;

EID: 84866953040     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2210-0     Document Type: Article

References (22)

1. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676-1687
2. Pickering M, Cook HT (2011) Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens 20:271-277
3. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376:794-801
4. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844-1859
5. Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. doi:10.1038/ki.2012.63
6. Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M (2003) Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 12:3385
7. Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Carreras Berges L, López-Trascasa M, Sánchez-Corral P, Rodríguez de Córdoba S (2005) Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14:703-712
8. Saunders RE, Goodship TH, Zipfel PF, Perkins SJ (2006) An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 27:21-30
9. Zipfel PF, Mache C, Muller D, Licht C, Wigger M, Skerka C, European DEAP-HUS Study group (2010) DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol 25:2009-2019
10. Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12:297-307
11. Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B (2005) Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15. Am J Kidney Dis 45:415-421
12. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smover W, Tully HF, Tully SP, Walker P, Welsh M, Wurzner R, Zipfel PF (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16:1392-1403
13. Dragon-DureyMA, Frémeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschennes G, Coppo P, Herman Friedman W, Weiss L (2004) Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 15:787-795
14. Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Boudouin V, Deschenes G, Macher MA, Loirat C (2010) Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation. Pediatr Nephrol 26:419-424
15. Sethi S, Fervenza C (2012) Membranoproliferative glomerulonephritis. A new look at an old entity. N Engl J Med 366:1119-1131
16. Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Zozsi M (2009) Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: indications for a disease spectrum and common pathogenic principles. Mol Immunol 46:2801-2807
17. Vaziri-Sani F, Holmberg L, Sjöholm AG, Kristofferson A-C, Manea M, Frémeaux-Bacchi V, Fehrman-Ekholm I, Raafat R, Karpman D (2006) Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 69:981-988
18. Lorcy N, Rioux-Leclercq N, Lombard ML, Le Pogamp P, Vigneau C (2011) Three kidneys, two diseases, one antibody? Nephrol Dial Transplant 26:3811-3813
19. Boyer O, Noël LH, Balzamo E, Guest G, Biebuyck N, Charbit M, Salomon R, Frémeaux-Bacchi V, Niaudet P (2008) Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits. Am J Kidney Dis 51:671-677
20. El Karoui K, Hill GS, Karras A, Jacquot C, Moulonguet L, Kourilsky O, Frémeaux-Bacchi V, Delahousse M, Van Huyen JP, Loupy A, Bruneval P, Nochy D (2012) A clinicopathologic study of thrombotic michroangiopathy in IgA nephropathy. J Am Soc Nephrol 23:137-148
21. Riedl M, Rosales A, Zimmerhackl LB, Jungraithmayr T (2011) Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H. Pediatr Transplant 15:225-228
22. Waters AM, Licht C (2011) aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol 26:41-57